These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30957583)

  • 1. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update.
    Lucarelli G; Loizzo D; Ferro M; Rutigliano M; Vartolomei MD; Cantiello F; Buonerba C; Di Lorenzo G; Terracciano D; De Cobelli O; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):377-387. PubMed ID: 30957583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
    Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
    Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.
    Li J; Ren S; Piao HL; Wang F; Yin P; Xu C; Lu X; Ye G; Shao Y; Yan M; Zhao X; Sun Y; Xu G
    Sci Rep; 2016 Feb; 6():20984. PubMed ID: 26865432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells.
    Burch TC; Isaac G; Booher CL; Rhim JS; Rainville P; Langridge J; Baker A; Nyalwidhe JO
    PLoS One; 2015; 10(8):e0134206. PubMed ID: 26244785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.
    Andersen MK; Rise K; Giskeødegård GF; Richardsen E; Bertilsson H; Størkersen Ø; Bathen TF; Rye M; Tessem MB
    Sci Rep; 2018 Sep; 8(1):14269. PubMed ID: 30250137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
    Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
    Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
    Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
    Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fat side of prostate cancer.
    Zadra G; Photopoulos C; Loda M
    Biochim Biophys Acta; 2013 Oct; 1831(10):1518-32. PubMed ID: 23562839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Proteome of Primary Prostate Cancer.
    Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
    Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
    Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
    Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into lipid metabolism and prostate cancer (Review).
    Zhang Z; Wang W; Kong P; Feng K; Liu C; Sun T; Sang Y; Duan X; Tao Z; Liu W
    Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37203395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer.
    Pardo JC; Ruiz de Porras V; Gil J; Font A; Puig-Domingo M; Jordà M
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.
    Shao Y; Ye G; Ren S; Piao HL; Zhao X; Lu X; Wang F; Ma W; Li J; Yin P; Xia T; Xu C; Yu JJ; Sun Y; Xu G
    Int J Cancer; 2018 Jul; 143(2):396-407. PubMed ID: 29441565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.